Esperion Therapeutics Inc - ESG Rating & Company Profile powered by AI
This dashboard includes a questions and answers table for Esperion Therapeutics Inc. Alternative companies in the scoring industry group for Esperion Therapeutics Inc are displayed. Detailed ESG assessment of Esperion Therapeutics Inc can be accessed by logging in.
Esperion Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.4; made up of an environmental score of 4.0, social score of 0.0 and governance score of 3.2.
2.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1499 | Verici Dx Plc | 2.5 | Medium |
| 1499 | Verve Therapeutics Inc | 2.5 | Medium |
| 1512 | Esperion Therapeutics Inc | 2.4 | Medium |
| 1512 | CEL-SCI Corp | 2.4 | Medium |
| 1512 | Allena Pharmaceuticals Inc | 2.4 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Esperion Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Esperion Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Esperion Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Esperion Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Esperion Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Esperion Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Esperion Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Esperion Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Esperion Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Esperion Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Esperion Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Esperion Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Esperion Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Esperion Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Esperion Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Esperion Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Esperion Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Esperion Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.